Combination strategies with checkpoint immunotherapy and inducers of immunogenic cell death (ICD) in immune competent syngeneic models

被引：0
|
作者：
McKenzie, A. [1 ]
Papadopoulou, N. [1 ]
Yin, Y. [1 ]
Jiang, S. [1 ]
Wrigley, J. [2 ]
King, J. [3 ]
Garland, R. [4 ]
Williams, N. [5 ]
Kumari, R. [6 ]
机构：
[1] Crown Biosci UK Ltd, Sci Operat, Loughborough, Leics, England
[2] Crown Biosci UK Ltd, Vitro Operat, Loughborough, Leics, England
[3] Crown Biosci UK Ltd, Vivo Operat, Loughborough, Leics, England
[4] KWS Biotest, Analyt Serv, Bristol, Avon, England
[5] KWS Biotest, Bristol, Avon, England
[6] Crown Biosci UK Ltd, CBUK, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32931-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
338
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [31] Combination of local mRNA immunotherapy with systemic immune checkpoint blockade demonstrates antitumor activity across a diverse range of preclinical syngeneic tumor models
    Malkova, Natalia, V
    Tolstykh, Tatiana
    Levit, Mikhail
    Theilhaber, Joachim
    Hebert, Andrew
    Atchison, Kevin
    Maisonet, Adalis
    Hotz, Christian
    Sahin, Ugur
    Protopopov, Alexei
    Pollard, Jack
    Sidhu, Sukhvinder
    Wiederschain, Dmitri
    Wagenaar, Timothy R.
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
    Amirhossein Mardi
    Anastasia V. Shirokova
    Rebar N. Mohammed
    Ali Keshavarz
    Angelina O. Zekiy
    Lakshmi Thangavelu
    Talar Ahmad Merza Mohamad
    Faroogh Marofi
    Navid Shomali
    Amir Zamani
    Morteza Akbari
    Cancer Cell International, 22
  • [33] Transformable prodrug nanoplatform via tumor microenvironment modulation and immune checkpoint blockade potentiates immunogenic cell death mediated cancer immunotherapy
    Yang, Weijing
    Yi, Jinmeng
    Zhu, Rongrong
    Guo, Yichen
    Zhang, Kaixin
    Cao, Yongjian
    Li, Xinyan
    Zhang, Jinjie
    Zhang, Zhenzhong
    Li, Yongjuan
    Chen, Xiaoyuan
    THERANOSTICS, 2023, 13 (06): : 1906 - 1920
  • [34] Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
    Mardi, Amirhossein
    Shirokova, Anastasia, V
    Mohammed, Rebar N.
    Keshavarz, Ali
    Zekiy, Angelina O.
    Thangavelu, Lakshmi
    Mohamad, Talar Ahmad Merza
    Marofi, Faroogh
    Shomali, Navid
    Zamani, Amir
    Akbari, Morteza
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [35] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
    Sparks, R.
    Rolland, S.
    Klinz, S.
    Meyer-Losic, F.
    Nakhle, J.
    Delille, R.
    de Boisferonc, M. Hillairet
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] ARMED MYXOMA VIRUS DEMONSTRATES EFFICACY IN SYNGENEIC TUMOR MODELS ALONE AND IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS
    Franco, Lina
    Torres-Dominguez, Lino
    Mamola, Joseph
    de Matos, Ana
    Abrantes, Mario
    Walker, Benjamin
    Tacner, Zachary
    Kien, Cassandra
    Elliott, Natalie
    McFadden, Grant
    Sharp, Leslie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A356 - A356
  • [38] Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy
    Xie, Lisi
    Wang, Guohao
    Sang, Wei
    Li, Jie
    Zhang, Zhan
    Li, Wenxi
    Yan, Jie
    Zhao, Qi
    Dai, Yunlu
    BIOMATERIALS, 2021, 269
  • [39] Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML)
    Wen, Shuang
    Lv, Xuefeng
    Ma, Xiaohan
    Deng, Shu
    Xie, Jinming
    Yuan, Enwu
    FRONTIERS IN GENETICS, 2024, 15
  • [40] Evaluation of tumour infiltrating immune cells into the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models in immune competent mice following treatment with checkpoint inhibitors
    Andrew, M.
    Nektaria, P.
    Simon, J.
    Jane, W.
    Jason, K.
    Vicky, L.
    Kelly, J.
    Russell, G.
    Neil, W.
    Kumari, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S111 - S111
12345